Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isometheptene is a sympathomimetic amine used primarily for the treatment of migraines and tension headaches due to its vasoconstricting properties. It acts by constricting dilated cranial and cerebral arterioles, thereby reducing the stimuli that lead to vascular headaches. Isometheptene exerts its effects through activation of the sympathetic nervous system via epinephrine and norepinephrine, which interact with adrenergic receptors on smooth muscle cells, leading to increased intracellular calcium and subsequent vasoconstriction. The drug may also have a mixed mechanism involving both tyramine-like action (indirectly releasing catecholamines) and direct stimulation of α1-adrenoceptors[1][5][6]. Isometheptene is often formulated as the mucate salt in combination products for headache relief.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isometheptene.